Showing results (4901-4910 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|February 23, 2013
One-year effect of a nurse-led psychosocial intervention on depressive symptoms in patients with head and neck cancer: a randomized controlled trialIngeborg C van der Meulen, Anne M May, Wynand J G Ros, et al.
The Oncologist|May 3, 2013
Prospective head and neck cancer research: a four-decade bibliometric perspectiveGordon H Sun, Jeffrey J Houlton, Nicholas M Moloci, et al.
The Oncologist|May 3, 2013
Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressive HER2-positive breast cancers, especially in luminal-B subtype, compared with a once-every-3-weeks scheduleKe-Da Yu, Guang-Yu Liu, Can-Ming Chen, et al.
The Oncologist|March 15, 2013
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomasHope E Uronis, Johanna C Bendell, Ivy Altomare, et al.
The Oncologist|January 24, 2013
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancerEmmanuel S Antonarakis, Elisabeth I Heath, David C Smith, et al.
The Oncologist|January 25, 2013
Lymph node ratio predicts recurrence in papillary thyroid cancerDavid F Schneider, Haggi Mazeh, Herbert Chen, et al.
The Oncologist|January 25, 2013
The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agentsKyle W Robinson, Alan B Sandler
The Oncologist|January 5, 2013
Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancyNadine J McCleary, Devin Wigler, Donna Berry, et al.
The Oncologist|January 5, 2013
Tissue factor as a novel target for treatment of breast cancerMarion Cole, Michael Bromberg
The Oncologist|January 5, 2013
"Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancerJan Schildmann, Jacinta Tan, Sabine Salloch, et al.
Pageof 571